Nevertheless, despite such advances in insulin development, many patients with type 1 diabetes (T1D) or insulin-dependent type 2 diabetes (T2D) remain unable to control postprandial hyperglycemia and hence meet or maintain HbA1c targets. This evidence concerns the gene INS and type 1 diabetes mellitus.